18 participants
Pembrolizumab in Neoplasms or Lymphomas
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2017-12-07
- Completion:
- 2022-08-18
Conditions
- Lymphoma
- Histiocytic Sarcoma
- Follicular Dendritic Cell Sarcoma
- Interdigitating Dendritic Cell Sarcoma
Interventions
- DRUG